Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology(2023)

引用 3|浏览37
暂无评分
摘要
Lower physical activity, higher BMI, diabetes, and longer planned treatment duration, but not celecoxib use or vitamin B6 intake, may be associated with significantly increased OIPN severity.
更多
查看译文
关键词
colon cancer,stage iii colon cancer,adjuvant therapy,oxaliplatin-induced
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要